• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国患者择期经皮冠状动脉介入治疗相关的心肌损伤:一项回顾性研究。

Myocardial damage associated with elective percutaneous coronary intervention in Chinese patients: a retrospective study.

机构信息

Department of Cardiovascular Disease, Huashan Hospital, Fudan University, Shanghai, China.

*These authors (Shengjia Sun and Yang Ou) contributed equally to this work.

出版信息

J Int Med Res. 2020 Mar;48(3):300060520907783. doi: 10.1177/0300060520907783.

DOI:10.1177/0300060520907783
PMID:32228089
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7133405/
Abstract

OBJECTIVE

To determine the prevalence of percutaneous coronary intervention (PCI) related myocardial damage (injury or myocardial infarction), investigate several cardiac biomarkers, explore possible risk factors and assess survival in patients undergoing elective PCI.

METHODS

Patients >18 years of age who had undergone an elective PCI at Huashan hospital in Shanghai, China from October 2016 to June 2017 and had baseline and post-PCI results available for four cardiac biomarkers (cTnT, CK-MB mass, hs-CRP and NT-ProBNP) were eligible. Patients were separated into two groups according to whether or not they had PCI related myocardial damage.

RESULTS

Of the 143 patients who were eligible for the study, 75 (52%) were classified as ‘controls,’ and 68 (48%) had PCI related myocardial damage. Of the 68 patients, 64 (45%) had PCI related myocardial injury and 4 (3%) had PCI related myocardial infarction. Elderly Chinese patients, with high systolic blood pressure on admission and who required multiple coronary segments for PCI had a high risk of myocardial damage. Relative cTnT or relative CK-MB mass may be useful cardiac biomarkers for monitoring PCI related myocardial damage, especially at 24h post-PCI. There was no significant difference in survival rates between controls and those with myocardial complications.

CONCLUSIONS

PCI related myocardial damage is common but appears to have no impact on prognosis. Senior age, high systolic blood pressure and multiple coronary segments for PCI are risk factors.

摘要

目的

确定经皮冠状动脉介入治疗(PCI)相关心肌损伤(损伤或心肌梗死)的发生率,研究几种心脏生物标志物,探讨可能的危险因素,并评估接受择期 PCI 患者的生存率。

方法

2016 年 10 月至 2017 年 6 月在上海华山医院接受择期 PCI 的年龄>18 岁的患者,基线和 PCI 后有四种心脏生物标志物(cTnT、CK-MB 质量、hs-CRP 和 NT-ProBNP)的结果可用,符合条件。患者根据是否存在 PCI 相关心肌损伤分为两组。

结果

在 143 名符合研究条件的患者中,75 名(52%)被归类为“对照组”,68 名(48%)有 PCI 相关心肌损伤。在 68 名患者中,64 名(45%)有 PCI 相关心肌损伤,4 名(3%)有 PCI 相关心肌梗死。高龄、入院时收缩压高且需要多支冠状动脉段进行 PCI 的中国老年患者,心肌损伤风险较高。相对 cTnT 或相对 CK-MB 质量可能是监测 PCI 相关心肌损伤的有用心脏生物标志物,尤其是在 PCI 后 24 小时。对照组和心肌并发症患者的生存率无显著差异。

结论

PCI 相关心肌损伤很常见,但似乎对预后没有影响。高龄、收缩压高和多支冠状动脉段进行 PCI 是危险因素。

相似文献

1
Myocardial damage associated with elective percutaneous coronary intervention in Chinese patients: a retrospective study.中国患者择期经皮冠状动脉介入治疗相关的心肌损伤:一项回顾性研究。
J Int Med Res. 2020 Mar;48(3):300060520907783. doi: 10.1177/0300060520907783.
2
Periprocedural use of tirofiban in elective percutaneous coronary intervention for long coronary lesions in stable patients with overlapping drug-eluting stents--the PETITION study: a prospective, randomized, multicenter study.替罗非班在置入药物洗脱支架的稳定型患者择期经皮冠状动脉介入治疗长冠状动脉病变围手术期的应用——PETITION研究:一项前瞻性、随机、多中心研究
Catheter Cardiovasc Interv. 2015 Mar;85 Suppl 1:762-9. doi: 10.1002/ccd.25864.
3
Correlates and outcomes related to periprocedural myocardial injury during percutaneous coronary intervention for chronic total occlusion: Results from a prospective, single center PCI registry.慢性完全闭塞病变经皮冠状动脉介入治疗围手术期心肌损伤的相关因素及预后:一项前瞻性单中心PCI注册研究的结果
Catheter Cardiovasc Interv. 2016 Mar;87 Suppl 1:616-23. doi: 10.1002/ccd.26406. Epub 2016 Feb 10.
4
Presence of sigma shaped right coronary artery is an indicator of poor prognosis in patients with inferior myocardial infarction treated with primary percutaneous coronary intervention.存在σ形右冠状动脉是接受直接经皮冠状动脉介入治疗的下壁心肌梗死患者预后不良的一个指标。
Catheter Cardiovasc Interv. 2014 Nov 15;84(6):965-72. doi: 10.1002/ccd.25388. Epub 2014 Feb 12.
5
Impact of multi-vessel therapy to the risk of periprocedural myocardial injury after elective coronary intervention: exploratory study.多支血管治疗对择期冠状动脉介入术后围手术期心肌损伤风险的影响:探索性研究
BMC Cardiovasc Disord. 2017 Feb 27;17(1):69. doi: 10.1186/s12872-017-0501-x.
6
Biomarker release after percutaneous coronary intervention in patients without established myocardial infarction as assessed by cardiac magnetic resonance with late gadolinium enhancement.通过心脏磁共振延迟钆增强评估的无确诊心肌梗死患者经皮冠状动脉介入术后生物标志物的释放情况。
Catheter Cardiovasc Interv. 2017 Jul;90(1):87-93. doi: 10.1002/ccd.27125. Epub 2017 Jun 2.
7
Contemporary Incidence, Management, and Long-Term Outcomes of Percutaneous Coronary Interventions for Chronic Coronary Artery Total Occlusions: Insights From the VA CART Program.慢性冠状动脉完全闭塞经皮冠状动脉介入治疗的当代发生率、处理方法和长期结局:来自 VA CART 项目的见解。
JACC Cardiovasc Interv. 2017 May 8;10(9):866-875. doi: 10.1016/j.jcin.2017.02.044.
8
Correlation of Admission Heart Rate With Angiographic and Clinical Outcomes in Patients With Right Coronary Artery ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: HORIZONS-AMI (The Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) Trial.接受直接经皮冠状动脉介入治疗的右冠状动脉ST段抬高型心肌梗死患者入院心率与血管造影及临床结局的相关性:HORIZONS-AMI(急性心肌梗死血管重建和支架置入的协调结局)试验
J Am Heart Assoc. 2017 Jul 19;6(7):e006181. doi: 10.1161/JAHA.117.006181.
9
Relationship of high-density lipoprotein cholesterol with periprocedural myocardial injury following elective percutaneous coronary intervention in patients with low-density lipoprotein cholesterol below 70 mg/dL.低密度脂蛋白胆固醇低于70mg/dL的患者在择期经皮冠状动脉介入治疗后高密度脂蛋白胆固醇与围手术期心肌损伤的关系
J Am Heart Assoc. 2015 Jan 8;4(1):e001412. doi: 10.1161/JAHA.114.001412.
10
Coronary artery calcium score in predicting periprocedural myocardial infarction in patients undergoing an elective percutaneous coronary intervention.冠状动脉钙化评分对择期经皮冠状动脉介入治疗患者围手术期心肌梗死的预测价值
Coron Artery Dis. 2018 Nov;29(7):589-596. doi: 10.1097/MCA.0000000000000651.

引用本文的文献

1
The Prognostic Value of Cardiac Troponin I in Patients with or without Three-Vessel Disease Undergoing Complete Percutaneous Coronary Intervention.心肌肌钙蛋白I在接受完全经皮冠状动脉介入治疗的有或无三支血管病变患者中的预后价值
J Clin Med. 2022 Jul 4;11(13):3896. doi: 10.3390/jcm11133896.
2
Epigallocatechin-3-gallate protects cardiomyocytes from hypoxia-reoxygenation damage via raising autophagy related 4C expression.没食子儿茶素没食子酸酯通过提高自噬相关蛋白 4C 的表达来保护心肌细胞免受缺氧复氧损伤。
Bioengineered. 2021 Dec;12(2):9496-9506. doi: 10.1080/21655979.2021.1996018.
3
Differentially expressed TUG1 and miR-145-5p indicate different severity of chronic heart failure and predict 2-year survival prognosis.

本文引用的文献

1
Fourth universal definition of myocardial infarction (2018).心肌梗死的第四次全球定义(2018年)。
Eur Heart J. 2019 Jan 14;40(3):237-269. doi: 10.1093/eurheartj/ehy462.
2
Relationship Between Preoperative Low-Density Lipoprotein Cholesterol and Periprocedural Myocardial Injury in Patients Following Elective Percutaneous Coronary Intervention in Southern China.中国南方地区择期经皮冠状动脉介入治疗患者术前低密度脂蛋白胆固醇与围术期心肌损伤的关系。
Med Sci Monit. 2018 Jun 18;24:4154-4161. doi: 10.12659/MSM.907400.
3
Prognostic and Practical Validation of Current Definitions of Myocardial Infarction Associated With Percutaneous Coronary Intervention.
差异表达的TUG1和miR-145-5p提示慢性心力衰竭的不同严重程度,并预测2年生存预后。
Exp Ther Med. 2021 Dec;22(6):1362. doi: 10.3892/etm.2021.10796. Epub 2021 Sep 27.
现行经皮冠状动脉介入治疗相关心肌梗死定义的预后和实用验证。
JACC Cardiovasc Interv. 2018 May 14;11(9):856-864. doi: 10.1016/j.jcin.2018.02.006.
4
Periprocedural myocardial infarction and injury in elective coronary stenting.择期冠状动脉支架置入术围术期心肌梗死和损伤。
Eur Heart J. 2018 Apr 1;39(13):1100-1109. doi: 10.1093/eurheartj/ehx799.
5
Impact of glycemic variability on the occurrence of periprocedural myocardial infarction and major adverse cardiovascular events (MACE) after coronary intervention in patients with stable angina pectoris at 6months follow-up.血糖变异性对稳定型心绞痛患者冠状动脉介入术后6个月随访时围手术期心肌梗死发生及主要不良心血管事件(MACE)的影响。
Clin Chim Acta. 2017 Aug;471:196-200. doi: 10.1016/j.cca.2017.06.014. Epub 2017 Jun 15.
6
Consensus or Controversy?: Evolution of Criteria for Myocardial Infarction After Percutaneous Coronary Intervention.共识还是争议?经皮冠状动脉介入治疗后心肌梗死的诊断标准演变
Clin Chem. 2017 Jan;63(1):82-90. doi: 10.1373/clinchem.2016.255208. Epub 2016 Nov 15.
7
High-Sensitivity Troponin T and Mortality After Elective Percutaneous Coronary Intervention.高敏肌钙蛋白 T 与择期经皮冠状动脉介入治疗后死亡率。
J Am Coll Cardiol. 2016 Nov 29;68(21):2259-2268. doi: 10.1016/j.jacc.2016.08.059.
8
Determinants and Prognostic Significance of Periprocedural Myocardial Injury in Patients With Successful Percutaneous Chronic Total Occlusion Interventions.经皮慢性完全闭塞介入治疗成功患者围手术期心肌损伤的决定因素及其预后意义。
JACC Cardiovasc Interv. 2016 Nov 14;9(21):2220-2228. doi: 10.1016/j.jcin.2016.08.005.
9
Association of chronic kidney disease with periprocedural myocardial injury after elective stent implantation: A single center prospective cohort study.择期支架植入术后慢性肾脏病与围手术期心肌损伤的关联:一项单中心前瞻性队列研究。
Medicine (Baltimore). 2016 Nov;95(45):e5381. doi: 10.1097/MD.0000000000005381.
10
Impact of neutrophil-to-lymphocyte ratio on periprocedural myocardial infarction in patients undergoing non-urgent percutaneous coronary revascularisation.中性粒细胞与淋巴细胞比值对非紧急经皮冠状动脉血运重建患者围手术期心肌梗死的影响。
Neth Heart J. 2016 Jul;24(7-8):462-74. doi: 10.1007/s12471-016-0850-6.